⌘K

Home/Filings/4/0001104659-20-130531

4//SEC Filing

Cavan John T 4

Accession 0001104659-20-130531

CIK 0001583771other

View on SEC.gov Company Profile

Filed

Nov 29, 7:00 PM ET

Accepted

Nov 30, 4:53 PM ET

Size

4.5 KB

Accession

0001104659-20-130531

Insider Transaction Report

Form 4

Period: 2020-11-25

Hepion Pharmaceuticals, Inc.HEPA

Chief Financial Officer

Transactions

Purchase
Common Stock
2020-11-25$1.62/sh+4,500$7,290→ 4,800 total

Documents

1 file

4
a4.xmlPrimary
4

Issuer

Hepion Pharmaceuticals, Inc.

CIK 0001583771

Entity typeother

Related Parties

1

filerCIK 0001503738

Filing Metadata

Form type: 4
Filed: Nov 29, 7:00 PM ET
Accepted: Nov 30, 4:53 PM ET
Size: 4.5 KB

View on SEC.gov